Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

479
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
479
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

560
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
560
Glaucoma: Overview01:25

Glaucoma: Overview

621
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
621

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ocular and Systemic Findings in COL2A1 and COL11A1 Stickler Syndrome.

American journal of medical genetics. Part A·2026
Same author

TRUE-MOGAD Score: A Novel Scoring System to Identify MOGAD Among Positive MOG-IgG Test Results.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

Epiretinal membranes in multiple sclerosis: A window into glial pathobiology?

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Blue Dacryorrhea After Inadvertent Infiltration of the Lacrimal Gland During Scleral Tattooing.

Cornea·2026
Same author

TRUE-MOGAD Score: A Novel Scoring System to Identify MOGAD Among Positive MOG-IgG Test Results.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

Investigating the Frequency and Outcome of Central Vein Sign and Paramagnetic Rim Lesions in Children With MOGAD.

Neurology·2026

Related Experiment Video

Updated: Jul 20, 2025

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

14.1K

An update on optic neuritis.

Jessica A Kraker1, John J Chen2,3

  • 1Department of Ophthalmology, Mayo Clinic Hospital, Rochester, MN, USA.

Journal of Neurology
|August 5, 2023
PubMed
Summary

Differentiating typical optic neuritis (ON) from atypical forms like MOGAD and NMOSD is crucial for effective treatment and prognosis. Early diagnosis through serologic testing guides tailored therapies for better patient outcomes.

Keywords:
Chronic relapsing inflammatory optic neuropathyMOG antibody-associated diseaseMultiple sclerosisNeuro-ophthalmologyNeuromyelitis optica spectrum disorderOptic neuritis

More Related Videos

The Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy rNAION
06:49

The Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy rNAION

Published on: November 20, 2016

9.0K
Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

11.5K

Related Experiment Videos

Last Updated: Jul 20, 2025

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

14.1K
The Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy rNAION
06:49

The Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy rNAION

Published on: November 20, 2016

9.0K
Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

11.5K

Area of Science:

  • Neuro-ophthalmology
  • Autoimmune Neurology

Background:

  • Optic neuritis (ON) is a common cause of optic neuropathy in young adults.
  • Typical ON is often idiopathic or linked to multiple sclerosis.
  • Atypical ON includes antibody-mediated conditions like MOGAD and NMOSD.

Purpose of the Study:

  • To highlight the importance of distinguishing typical from atypical ON.
  • To guide clinicians on recognizing and testing for atypical ON.
  • To emphasize the impact of etiology on prognosis and treatment.

Main Methods:

  • Review of clinical presentations of typical and atypical ON.
  • Discussion of diagnostic clues for atypical ON (e.g., severe vision loss, disc edema, bilateral involvement).
  • Emphasis on serologic testing for AQP4-IgG and MOG-IgG.

Main Results:

  • Atypical ON features like severe vision loss, steroid dependence, disc edema, and bilateral involvement warrant specific antibody testing.
  • While typical ON often has good recovery, atypical forms require distinct management strategies.
  • Rare autoimmune optic neuropathies (GFAP, CRMP5) should also be considered.

Conclusions:

  • Accurate diagnosis of ON etiology is paramount for appropriate treatment and improved patient outcomes.
  • Clinical features can sometimes blur the lines between typical and atypical ON, necessitating a high index of suspicion.
  • Tailored treatment based on specific autoimmune markers (AQP4-IgG, MOG-IgG) is essential for managing NMOSD and MOGAD.